These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Solubilities of testosterone propionate and related esters in organic solvents. James KC; Ng CT; Noyce PR J Pharm Sci; 1976 May; 65(5):656-9. PubMed ID: 932931 [TBL] [Abstract][Full Text] [Related]
9. Prediction of solubility in nonideal multicomponent systems using the UNIFAC group contribution model. Ochsner AB; Sokoloski TD J Pharm Sci; 1985 Jun; 74(6):634-7. PubMed ID: 4020650 [TBL] [Abstract][Full Text] [Related]
10. Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: a double-blind study. Flacke JW; Bloor BC; Kripke BJ; Flacke WE; Warneck CM; Van Etten AP; Wong DH; Katz RL Anesth Analg; 1985 Sep; 64(9):897-910. PubMed ID: 2862810 [TBL] [Abstract][Full Text] [Related]
11. Use of solubility parameters of drug and vehicle to predict flux through skin. Sloan KB; Koch SA; Siver KG; Flowers FP J Invest Dermatol; 1986 Aug; 87(2):244-52. PubMed ID: 3734472 [TBL] [Abstract][Full Text] [Related]
12. Comparison of four opioid analgesics as supplements to nitrous oxide anesthesia. Ghoneim MM; Dhanaraj J; Choi WW Anesth Analg; 1984 Apr; 63(4):405-12. PubMed ID: 6230953 [TBL] [Abstract][Full Text] [Related]
13. Comparison of dispersive liquid-liquid microextraction and hollow fiber liquid-liquid-liquid microextraction for the determination of fentanyl, alfentanil, and sufentanil in water and biological fluids by high-performance liquid chromatography. Saraji M; Khalili Boroujeni M; Hajialiakbari Bidgoli AA Anal Bioanal Chem; 2011 Jun; 400(7):2149-58. PubMed ID: 21442368 [TBL] [Abstract][Full Text] [Related]
14. Expanded solubility parameter approach. I: Naphthalene and benzoic acid in individual solvents. Beerbower A; Wu PL; Martin A J Pharm Sci; 1984 Feb; 73(2):179-88. PubMed ID: 6707879 [TBL] [Abstract][Full Text] [Related]
15. Predicting the solubility of sulfamethoxypyridazine in individual solvents. I: Calculating partial solubility parameters. Bustamante P; Escalera B; Martin A; Sellés E J Pharm Sci; 1989 Jul; 78(7):567-73. PubMed ID: 2778657 [TBL] [Abstract][Full Text] [Related]
16. Extended Hildebrand Solubility Approach: methylxanthines in mixed solvents. Martin A; Paruta AN; Adjei A J Pharm Sci; 1981 Oct; 70(10):1115-20. PubMed ID: 7299644 [TBL] [Abstract][Full Text] [Related]
17. Some relationships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications. Stella VJ; Martodihardjo S; Terada K; Rao VM J Pharm Sci; 1998 Oct; 87(10):1235-41. PubMed ID: 9758683 [TBL] [Abstract][Full Text] [Related]
18. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties. Hoye JA; Gupta A; Myrdal PB J Pharm Sci; 2008 Jan; 97(1):198-208. PubMed ID: 17828733 [TBL] [Abstract][Full Text] [Related]
19. Determination of solubilities and n-octanol/water partition coefficients and QSPR study for substituted phenols. Xie YJ; Liu H; Liu HX; Zhai ZC; Wang ZY Bull Environ Contam Toxicol; 2008 Apr; 80(4):319-23. PubMed ID: 18340399 [TBL] [Abstract][Full Text] [Related]